The medical perspective on burnout

International Journal of Occupational Medicine and Environmental Health

Volumn 26, Issue 3, 2013, Pages 401-412

  Kakiashvili, Tamar ^a   Leszek, Jerzy ^b   Rutkowski, Krzysztof ^c  

^a Sudbury Therapy   (Canada)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Burnout; Cortisol; Pathophysiology; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT;

BURNOUT; DIET SUPPLEMENTATION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; OCCUPATIONAL DISEASE; QUESTIONNAIRE; REVIEW;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BURNOUT, PROFESSIONAL; DIETARY SUPPLEMENTS; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OCCUPATIONAL DISEASES; PITUITARY-ADRENAL SYSTEM; QUESTIONNAIRES;

EID: 84884270999     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/s13382-013-0093-3     Document Type: Article

References (52)

1. Appels A. Why do imminent victims of a cardiac event feel so tired? Int J Clin Pract 1997;51:447-450.
2. Maslach C, Schaufeli WB, Leiter MP. Job burnout. Annu Rev Psychol 2001;52:397-422.
3. Hallman T, Thomsson H, Burell G, Lisspers J, Setterlind S. Stress, burnout and coping: differences between women with coronary heart disease and healthy matched women. J Health Psychol 2003;8(4):433-445.
4. Appels A, Mulder P. Fatigue and heart disease. The association between 'vital exhaustion' and past, present and future coronary heart disease. J Psychosom Res 1989;33:727-738.
5. Pedersen SS, Middel B. Increased vital exhaustion among type-D patients with ischemic heart disease. J Psychosom Res 2001;51(2):443-449.
6. Räikkönen K, Lassila R, Keltikangas-Järvinen L, Hautanen A. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men. Arterioscler Thromb Vasc Biol 1996;16(3):363-367.
7. Keltikangas-Järvinen L, Räikkönen K, Hautanen A, Adlercreutz H. Vital exhaustion, anger expression, and pituitary and adrenocortical hormones. Implications for the insulin resistance syndrome. Arterioscler Thromb Vasc Biol 1996;16(2):275-280.
8. Nicolson NA, van Diest R. Salivary cortisol patterns in vital exhaustion. J Psychosom Res 2000;49(5):335-342.
9. Sandstrom A, Rhodin IN, Lundberg M, Olsson T, Nyberg L. Impaired cognitive performance in patients with chronic burnout syndrome. Biol Psychol 2005;69:271-279.
10. Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response to cytokines in older adults. Health Psychol 1994;13:291-298.
11. Maslach C, Jackson SE, Leiter MP. Maslach Burnout Inventory. Palo Alto, CA: Consulting Psychologist Press; 1996.
12. Barbosa FT, Leao BA, Tavares GM, Santos JG. Burnout syndrome and weekly workload of on-call physicians: Cross-sectional study. Sao Paulo Med J 2012;130(5):282-288.
13. Farber BA. Burnout in psychotherapists: Incidence, types, and trends. Psychother Priv Pract 1990;8(1):35-44.
14. Farber BA. Treatment strategies for different types of teacher burnout. J Clin Psychol 2000;56:675-689.
15. Montero-Marín J, García-Campayo J, Mosquera Mera D, López del Hoyo Y. A new definition of burnout syndrome based on Farber's proposal. J Occup Med Toxicol 2009;4(31):1-17.
16. Montero-Marín J, García-Campayo J, Fajó-Pascual M, Carrasco JM, Gascón S, Gili M, et al. Sociodemographic and occupational risk factors associated with the development of different burnout types: The cross-sectional University of Zaragoza study. BMC Psychiatry 2011;11(49):1-13.
17. Trickett S. Withdrawal from benzodiazepines. J R Coll Gen Pract 1983;33:608.
18. Lader M, Morton S. Benzodiazepine problems. Br J Addict 1991;86:823-828.
19. Michelini S, Cassano GB, Frare F, Perugi G. Long-term use of benzodiazepines: Tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry 1996;29:127-134.
20. Opstad K. Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men. Eur J Endocrinol 1994;131:56-66.
21. Ekstedt M, Söderström M, Akerstedt T, Nilsson J, Søndergaard HP, Aleksander P. Disturbed sleep and fatigue in occupational burnout. Scand J Work Environ Health 2006;32(2):121-131.
22. Doghramji K. Approach to the patient with a sleep or wakefulness disorder. The Merck Manual Online. [cited 2013 June 20]. Available from http://www.merckmanuals.com/professional/neurologic-disorders/ sleep-and-wakefulness-disorders/approach-to-the-patient-with-a-sleep-or- wakefulness-disorder.html
23. Ahola K, Honkonen T, Virtanen M, Kivimäki M, Isometsä E, Aromaa A, et al. Interventions in relation to occupational burnout: The population-based health 2000 study. J Occup Environ Med 2007;49(9):943-952.
24. Juster RP, Sindi S, Marin MF, Perna A, Hashemi A, Pruessner JC, et al. A clinical allostatic load index is associated with burnout symptoms and hypocortisolemic profiles in healthy workers. Psychoneuroendocrinology 2011;36(6):797-805.
25. Sonnenschein M, Mommersteeg PM, Houtveen JH, Sorbi MJ, Schaufeli WB, van Doornen LJ. Exhaustion and endocrine functioning in clinical burnout: An in-depth study using the experience sampling method. Biol Psychol 2007;75(2):176-184.
26. Pariante CM, Hye A, Williamson R, Makoff A, Lovestone S, Kerwin RW. The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 2003;28:1553-1561. DOI: 10.1038/sj.npp.1300195.
27. Pariante CM, Kim RB, Makoff A, Kerwin RW. Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br J Pharmacol 2003;139:1111-1118.
28. Karssen AM, Meijer OC, van der Sandt I, Lucassen PJ, de Lange EC, de Boer AG, et al. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 2001;142(2):686-694.
29. Hotze SF. Adrenal Fatigue & Cortisol [cited 2013 June 20]. Available from http://www.cushings-help.com/downloads/adrenal.pdf
30. Schuder SE. Stress-Induced Hypocortisolemia Diagnosed as Psychiatric Disorders Responsive to Hydrocortisone Replacement. Ann N Y Acad Sci 2005;1057:466-478.
31. Sagud M, Pivac N, Mück-Seler D, Jakovljević M, Mihaljević-Peles A, Korsić M. Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 2002;45:139-143.
32. Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, et al. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: Implications for the treatment of alcoholism. Alcohol Clin Exp Res 1998;22(7):1430-1436.
33. Petrosino S, Di Marzo V. FAAH and MAGL inhibitors: Therapeutic opportunities from regulating endocannabinoid levels. Curr Opin Invest Drugs 2010;11(1):51-62.
34. Guilliams TG, Edwards L. Chronic stress and the HPA axis: Clinical assessment and therapeutic considerations. The review of natural & neutraceutical therapies for clinical practice. Standard 2010;9(2):1-12.
35. Hamazaki K, Itomura M, Huan M. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: A randomized, placebo-controlled, double-blind trial. Nutrition 2005;21:705-710.
36. Delarue J, Matzinger O, Binnert C. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab 2003;29:289-295.
37. Hamazaki T, Itomura M, Sawazaki S, Nagao Y. Antistress effects of DHA. Biofactors 2000;13:41-45.
38. Krähenbühl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab 1994;78(3):581-585.
39. Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 2006;46(3):167-192.
40. Head KH, Kelly GS. Nutrients and botanicals for treatment of stress: Adrenal fatigue, neurotransmitter imbalance, anxiety, and restless sleep. Altern Med Rev 2009;14(2):114-140.
41. Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol 2009;4(3):198-219.
42. Pruessner JC, Hellhammer DH, Kirschbaum C. Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med 1999;61(2):197-204.
43. Clarke DM, Kissane DW. Demoralization: Its phenomenology and importance. Aust N Z J Psychiatry 2002;36(6):733-742.
44. Gabel S. Demoralization in mental health organizations: Leadership and social support help. Psychiatr Q 2012;83(4):489-496.
45. West CP, Dyrbye LN, Satele DV, Sloan JA, Shanafelt TD. Concurrent validity of single-item measures of emotional exhaustion and depersonalization in burnout assessment. Gen Intern Med 2012;27(11):1445-1452.
46. Greaves-Lord K, Ferdinand RF, Oldehinkel AJ, Sondeijker FE, Ormel J, Verhulst FC. Higher cortisol awakening response in young adolescents with persistent anxiety problems. Acta Psychiatr Scand 2007;116(2):137-144.
47. Kanter ED, Wilkinson CW, Radant AD, Petrie EC, Dobie DJ, McFall ME, et al. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol Psychiatry 2001;50(4):238-245.
48. Moch SL, Panz VR, Joffe BI, Havlik I, Moch JD. Longitudinal changes in pituitaryadrenal hormones in South African women with burnout. Endocrine 2003;21(3):267-272.
49. Kellner M, Yehuda R, Arlt J, Wiedemann K. Longitudinal course of salivary cortisol in post-traumatic stress disorder. Acta Psychiatr Scand 2002;105(2):153-155
50. Yehuda R, Brand SR, Golier JA, Yang RK. Clinical correlates of DHEA associated with post-traumatic stress disorder. Acta Psychiatr Scand 2006;114(3):187-193.
51. Tiller JW, Biddle N, Maguire KP, Davies BM. The dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder. Biol Psychiatry 1988;23(3):261-270.
52. Montero-Marín J. The 'Burnout Clinical Subtype Questionnaire' (BCSQ-36/BCSQ-12): A new definition of burnout through a differential characterization of the syndrome. Huesca: Ediciones GH; 2012. p. 106.